Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Greenberg

Showing results (91-100 of 153) with videos related to

Pageof 16
Sort By:
Blood|April 1, 1994
Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxisC R Li, P D Greenberg, M J Gilbert, et al.
Progress in Clinical and Biological Research|January 1, 1987
Effector mechanisms by which adoptively transferred T cells promote tumor eradicationP D Greenberg, D E Kern, M C Jensen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1988
IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytesD J Peace, D E Kern, K R Schultz, et al.
The Journal of Experimental Medicine|February 1, 1989
FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigensJ P Klarnet, D E Kern, K Okuno, et al.
Science (New York, N.Y.)|August 24, 1990
The role of B cells for in vivo T cell responses to a Friend virus-induced leukemiaK R Schultz, J P Klarnet, R S Gieni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1988
Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumorD E Kern, D J Peace, J P Klarnet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failureS J Kent, P D Greenberg, M C Hoffman, et al.
Journal of Virology|January 3, 2001
Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate modelC Berger, M L Huang, M Gough, et al.
Progress in Clinical and Biological Research|January 1, 1989
Specific adoptive immunotherapyP D Greenberg, J P Klarnet, D E Kern, et al.
Cancer Treatment Reports|June 1, 1982
Treatment of refractory acute nonlymphocytic leukemia with a combination of pyrazofurin and cytarabineH G Kaplan, F R Appelbaum, M A Cheever, et al.
Pageof 16

Showing results (91-100 of 153) with videos related to

Sort By:
Pageof 16
Blood|April 1, 1994
Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxisC R Li, P D Greenberg, M J Gilbert, et al.
Progress in Clinical and Biological Research|January 1, 1987
Effector mechanisms by which adoptively transferred T cells promote tumor eradicationP D Greenberg, D E Kern, M C Jensen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1988
IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytesD J Peace, D E Kern, K R Schultz, et al.
The Journal of Experimental Medicine|February 1, 1989
FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigensJ P Klarnet, D E Kern, K Okuno, et al.
Science (New York, N.Y.)|August 24, 1990
The role of B cells for in vivo T cell responses to a Friend virus-induced leukemiaK R Schultz, J P Klarnet, R S Gieni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1988
Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumorD E Kern, D J Peace, J P Klarnet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failureS J Kent, P D Greenberg, M C Hoffman, et al.
Journal of Virology|January 3, 2001
Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate modelC Berger, M L Huang, M Gough, et al.
Progress in Clinical and Biological Research|January 1, 1989
Specific adoptive immunotherapyP D Greenberg, J P Klarnet, D E Kern, et al.
Cancer Treatment Reports|June 1, 1982
Treatment of refractory acute nonlymphocytic leukemia with a combination of pyrazofurin and cytarabineH G Kaplan, F R Appelbaum, M A Cheever, et al.
Pageof 16